Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Block

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Cancer Treatment Reports|January 1, 1982
Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell lineR T Chlebowski, J B Block, D Cundiff, et al.
Oncology|January 1, 1973
Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's diseaseK Brace, A A Serpick, J B Block, et al.
Cancer Treatment Reports|April 1, 1984
Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibitionJ B Block, R T Chlebowski, M F Dietrich, et al.
Cancer Research|November 1, 1985
Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol poolS A Akman, M Dietrich, R Chlebowski, et al.
Cancer Research|November 1, 1982
Abnormalities in glucose and protein metabolism in noncachectic lung cancer patientsD Heber, R T Chlebowski, D E Ishibashi, et al.
The Journal of Clinical Investigation|June 1, 1972
Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in manP L Weiden, R M Blaese, W Strober, et al.
Cancer|August 15, 1983
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trialR T Chlebowski, R Pugh, J M Weiner, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1970
Clinical experience with L-asparaginaseP P Carbone, C M Haskell, B G Leventhal, et al.
Cancer Chemotherapy Reports|December 1, 1970
Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880)J A Gottlieb, A M Guarino, J B Call, et al.
Cancer Treatment Reports|March 1, 1984
Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic resultsR T Chlebowski, A Brzechwa-Adjukiewicz, A Cowden, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reports|January 1, 1982
Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell lineR T Chlebowski, J B Block, D Cundiff, et al.
Oncology|January 1, 1973
Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's diseaseK Brace, A A Serpick, J B Block, et al.
Cancer Treatment Reports|April 1, 1984
Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibitionJ B Block, R T Chlebowski, M F Dietrich, et al.
Cancer Research|November 1, 1985
Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol poolS A Akman, M Dietrich, R Chlebowski, et al.
Cancer Research|November 1, 1982
Abnormalities in glucose and protein metabolism in noncachectic lung cancer patientsD Heber, R T Chlebowski, D E Ishibashi, et al.
The Journal of Clinical Investigation|June 1, 1972
Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in manP L Weiden, R M Blaese, W Strober, et al.
Cancer|August 15, 1983
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trialR T Chlebowski, R Pugh, J M Weiner, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1970
Clinical experience with L-asparaginaseP P Carbone, C M Haskell, B G Leventhal, et al.
Cancer Chemotherapy Reports|December 1, 1970
Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880)J A Gottlieb, A M Guarino, J B Call, et al.
Cancer Treatment Reports|March 1, 1984
Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic resultsR T Chlebowski, A Brzechwa-Adjukiewicz, A Cowden, et al.
Pageof 7